{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T17:10:21Z","timestamp":1693674621776},"reference-count":35,"publisher":"Cambridge University Press (CUP)","issue":"S6","license":[{"start":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T00:00:00Z","timestamp":1415318400000},"content-version":"unspecified","delay-in-days":2411,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Spectr."],"published-print":{"date-parts":[[2008,4]]},"abstract":"<jats:p>Co-occurring psychiatric and alcohol use disorders can have devastating personal and societal effects, yet little evidence exists to guide clinical treatment. In the face of scant data, individual practitioners must rely instead on professional experience and those limited practice guidelines that currently exist. The American Psychiatric Association (APA) advises that failure to treat a concurrent psychiatric disorder reduces the likelihood that the treatment for a substance use disorder (SUD) will be effective. Indeed, the effects of nontreatment were demonstrated in a prospective study assessing alcohol-dependent patients for 1 year following hospitalization for alcohol dependence, in which untreated depression was directly associated with a shorter time to first drink. The results also showed that among those patients with depression (Slide 1), taking antidepressants at the time of discharge increased the likelihood of an individual remaining abstinent during the follow-up period.<\/jats:p>","DOI":"10.1017\/s109285290000290x","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T05:02:03Z","timestamp":1470114123000},"page":"7-9","source":"Crossref","is-referenced-by-count":6,"title":["Evidence-Based Pharmacotherapy for Mood and Anxiety Disorders with Concurrent Alcoholism"],"prefix":"10.1017","volume":"13","author":[{"given":"Kathleen T.","family":"Brady","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2014,11,7]]},"reference":[{"key":"S109285290000290X_ref021","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200666090-00005"},{"key":"S109285290000290X_ref018","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00032-5"},{"key":"S109285290000290X_ref017","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1983.04390010059007"},{"key":"S109285290000290X_ref012","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830030054009"},{"key":"S109285290000290X_ref008","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03530340025025"},{"key":"S109285290000290X_ref009","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.55.2.153"},{"key":"S109285290000290X_ref010","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(95)01161-6"},{"key":"S109285290000290X_ref006","first-page":"293","article-title":"Alcoholism and depression: a placebo controlled study with viloxazine","volume":"10","author":"Altamura","year":"1990","journal-title":"Int J Clin Pharmacol Res."},{"key":"S109285290000290X_ref022","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.64.4.660"},{"key":"S109285290000290X_ref005","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.15.1887"},{"key":"S109285290000290X_ref001","volume-title":"Practice Guideline for the Treatment of Patients with Substance Use Disorders","year":"2006"},{"key":"S109285290000290X_ref004","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.10.002"},{"key":"S109285290000290X_ref015","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2003.11.015"},{"key":"S109285290000290X_ref002","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.55.3.259"},{"key":"S109285290000290X_ref030","doi-asserted-by":"publisher","DOI":"10.1002\/da.20213"},{"key":"S109285290000290X_ref013","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200004000-00003"},{"key":"S109285290000290X_ref020","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.1.37"},{"key":"S109285290000290X_ref014","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000095346.32154.41"},{"key":"S109285290000290X_ref016","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00208-8"},{"key":"S109285290000290X_ref019","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200104000-00005"},{"key":"S109285290000290X_ref011","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1997.01830200024004"},{"key":"S109285290000290X_ref023","doi-asserted-by":"publisher","DOI":"10.1002\/da.1077"},{"key":"S109285290000290X_ref026","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.12.1982"},{"key":"S109285290000290X_ref028","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000156129.98265.57"},{"key":"S109285290000290X_ref027","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.5.485"},{"key":"S109285290000290X_ref029","unstructured":"29. Physicians Desk Reference 2006: Guide to Drug Interactions, Side Effects, and Indications. 60th ed. Montvale, NJ: Thomson PDR; 2006:1175\u20133419."},{"key":"S109285290000290X_ref031","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1992.tb00648.x"},{"key":"S109285290000290X_ref032","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1176\/ajp.143.7.867","article-title":"Outpatient treatment of patients with substance abuse and coexisting psychiatric disorders","volume":"143","author":"Kofoed","year":"1986","journal-title":"Am J Psychiatry."},{"key":"S109285290000290X_ref007","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(97)00509-X"},{"key":"S109285290000290X_ref033","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199806000-00011"},{"key":"S109285290000290X_ref034","first-page":"843","volume-title":"Abstracts of Papers, 26th Annual Scientific Meeting of the Research Society on Alcoholism, Ft. Lauderdale, FL, June 21\u201325, 2003","author":"Salloum","year":"2003"},{"key":"S109285290000290X_ref024","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199908000-00010"},{"key":"S109285290000290X_ref035","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.03.074"},{"key":"S109285290000290X_ref025","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.14.1837"},{"key":"S109285290000290X_ref003","unstructured":"3. Substance Abuse and Mental Health Services Administration, United States Department of Health and Human Services. Treatment Improvement Protocols (TIP) 9: Assessment and treatment of patients with coexisting mental illness and alcohol and other drug abuse. Rockville, MD; 2002."}],"container-title":["CNS Spectrums"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S109285290000290X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:02:24Z","timestamp":1556668944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S109285290000290X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":35,"journal-issue":{"issue":"S6","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S109285290000290X"],"URL":"https:\/\/doi.org\/10.1017\/s109285290000290x","relation":{},"ISSN":["1092-8529","2165-6509"],"issn-type":[{"value":"1092-8529","type":"print"},{"value":"2165-6509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}